Summary
Latest filing:
Mikhail Kalinichev is HEAD OF TRANSLATIONAL SCIENCE of Addex Therapeutics Ltd. (ADXN). 1 SEC Form 4 filing on record, dated 4 September 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Mikhail Kalinichev has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Mikhail Kalinichev's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Framework Ventures IV L.P. - $42.62M of SDEV open-market activity in the last 12 months
- Eric M. Dube - $41.35M of TVTX open-market activity in the last 12 months
- Jesse J. Geiger - $41.11M of MEDP open-market activity in the last 12 months
- Mark Hancock - $40.97M of PACS open-market activity in the last 12 months
- EcoR1 Capital, LLC - $40.00M of AKTS open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M of BCAX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mikhail Kalinichev?
Mikhail Kalinichev is a corporate insider, tracked as HEAD OF TRANSLATIONAL SCIENCE of Addex Therapeutics Ltd. (ADXN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mikhail Kalinichev submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Mikhail Kalinichev's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mikhail Kalinichev and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
